Don't show this message again
◆ Ophthalmic Consultants PA in Sarasota, Florida, agreed to pay $4.8 million to settle false claims allegations that it billed Medicare and other federal payers for multi-dosing patients from single-use vials of ranibizumab and Eylea, the U.S. Attorney’s Office for the Middle District of Florida said June 30.[1] The practice didn’t admit liability in the settlement.